The chief scientific officer of cell therapy at Poseida Therapeutics discussed the company’s CAR-T and TCR technologies.
Devon J. Shedlock, PhD
Advertisement
Articles by Devon J. Shedlock, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Sangamo Starts Putting BLA for Fabry Disease Gene Therapy Isa-Vec in Front of FDA
2
CGTLive®’s Weekly Rewind – December 19, 2025
3
The Implications of the Final Data From Hemgenix’s HOPE-B Trial
4
What the Field of Cell and Gene Therapy Needs Most in the Current Moment
5